MITRAL VALVE REPAIR SurgiFrost is used to treat atrial fibrillation during mitral valve repair. Surgeons use the system during a well-established procedure (the Maze procedure) that is safe and effective. The use of the Maze procedure adds just a little more time to the operation. Treating atrial fibrillation in this manner has a positive impact on the patient’s lifestyle and reduces the potential for stroke. It also reduces the patient’s need for anti-arrhythmic and anti-coagulant medications as well as the side effects associated with them. Routinely used in more than 125 surgical centers around the world, the SurgiFrost system uses a malleable, single-use surgical cryoprobe to treat cardiac arrhythmias while a patient is undergoing a primary cardiac surgical procedure such as coronary artery bypass grafting (CABG) or mitral valve (MV) repair and/or replacement. CryoCath estimates that there are more than 375,000 patients annually worldwide who are candidates for a combined arrhythmia ablation with the CABG or MV procedure. SurgiFrost may ultimately be used on a primary basis for certain surgical procedures such as the stand-alone treatment of AF. |mitral valve repair|supraventricular tachycardia|cryoablation|ablation|